Epsilon M&A Deal Report - Newpharma
Transaction Multiples for the Valuation of Private Companies
Colruyt Group / Newpharma
No EMAT :
108140
Announced Date :
08/07/2021
Type :
Acquisition of Minority Stake
Deal Value :
Yes
Acquirer :
Colruyt Group
Target :
Newpharma
Country :
Belgium
Sector of activity :
- Internet > e-commerce (B2C)
- Retail and Wholesale ('R&W') > Pharmaceuticals & Cosmetics R&W
Business Description :
Founded in 2006 by Jérôme Gobbesso and Mike Vandenhooft , Newpharma an online provider of parapharmaceutical and over-the-counter products. > Product range includes beauty & cosmetics, vitamins &...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « e-commerce (B2C) » = 277
- Number of EMAT Reports / sub-sector « Pharmaceuticals & Cosmetics R&W » = 74
| Date | Acquirer | Target | Country | Multiples | See details |
| 01/07/2016 | Pharmacy2U | Direct Healthcare (Chemist Direct) | United Kingdom | ** | 108119 |
| 25/02/2021 | Private group led by Isatis Capital, BNP Paribas Développement | Sagitta Pharma (T&J Healthcare) | Indre-Et-Loire | * | 107980 |
Source: Epsilon Research / EMAT
